Daniel Soffer

A MASTER PROTOCOL FOR A PHASE 3, MULTICENTER, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF REGN7508 AND REGN9933, MONOCLONAL ANTIBODIES AGAINST FACTOR XI, IN PARTICIPANTS WITH RECENT LOWER EXTREMITY REVASCULARIZATION FOR SYMPTOMATIC PERIPHERAL ARTERY DISEASE (ROXI-PALISADE)

MagicTouch - Sirolimus-Coated Balloon for treatment of Coronary Artery Lesions in Small Vessels

Magical RCT CTA

A Prospective Randomized Single-Blind Multicenter Study to Assess the Safety and Efficacy of the SELUTION SLR™ 014 PTCA Drug Eluting Balloon in in the Treatment of Subjects with De Novo Coronary Lesions in Small Vessels

Efficacy of the COronary SInus Reducer in Patients with Refractory Angina II (COSIRA-II)

MedAlliance Selution ISR IDE

Allay Study

The Protect IV Trial

“{“CGUARD – An Investigation of a Neuroprotective Stent A Multicenter, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the CGuard™ Carotid Stent System When Used to Treat Symptomatic and Asymptomatic Carotid Artery Stenosis in Patients Undergoing Carotid Artery Stenting. (“C-Guardians”PROTOCOL TITLE}” in accordance with Sponsor’s protocol number PRO-9017

Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial

CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL (CREST-2) PROTOCOL

Global multicenter, open-label, randomized, event-driven, activecontrolled study comparing a rivAroxaban-based antithrombotic strategy to an antipLatelet-based strategy after transcatheter aortIc vaLve rEplacement (TAVR) to Optimize clinical outcomes.

AN INTERNATIONAL MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBOCONTROLLED PHASE 3 TRIAL INVESTIGATING THE EFFICACY AND ....